Aerogen, Inc.
Records under this name other than patents Aerogen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,616,195 | Nebuliser for the production of aerosolized medication now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 7,771,642 | Methods of Making an Apparatus for Providing Aerosol for Medical Treatment now held by Novartis AG Term ended Term ended Apr 11, 2026 · High confidence | Term ended | Term ended Apr 11, 2026 | High confidence |
| US 7,360,536 | Devices and Methods for Nebulizing Fluids for Inhalation now held by Novartis Pharma AG Term ended Term ended Aug 22, 2025 · High confidence | Term ended | Term ended Aug 22, 2025 | High confidence |
| US 7,946,291 | Ventilation Systems and Methods Employing Aerosol Generators now held by Novartis AG Term ended Ended no later than Jun 22, 2025 · Medium confidence | Term ended | Ended no later than Jun 22, 2025 | Medium confidence |
| US 8,539,944 | Devices and Methods for Nebulizing Fluids for Inhalation now held by Novartis AG Term ended Term ended May 4, 2025 · High confidence | Term ended | Term ended May 4, 2025 | High confidence |
| US 7,290,541 | Aerosol Delivery Apparatus and Method for Pressure-Assisted Breathing Systems now held by Novartis Pharma AG Term ended Ended no later than Nov 17, 2024 · Medium confidence | Term ended | Ended no later than Nov 17, 2024 | Medium confidence |
| US 7,267,121 | Aerosol Delivery Apparatus and Method for Pressure-Assisted Breathing Systems now held by Novartis AG Term ended Ended no later than Aug 4, 2024 · Medium confidence | Term ended | Ended no later than Aug 4, 2024 | Medium confidence |
| US 7,971,588 | Methods and Systems for Operating an Aerosol Generator now held by Novartis AG Term ended Term ended Apr 30, 2024 · High confidence | Term ended | Term ended Apr 30, 2024 | High confidence |
| US 7,201,167 | Method and Composition for the Treatment of Lung Surfactant Deficiency or Dysfunction now held by Novartis AG Term ended Ended no later than Apr 20, 2024 · Medium confidence | Term ended | Ended no later than Apr 20, 2024 | Medium confidence |
| US 7,100,600 | Fluid Filled Ampoules and Methods for Their Use in Aerosolizers now held by Novartis Pharma AG Term ended Term ended Sep 18, 2023 · High confidence | Term ended | Term ended Sep 18, 2023 | High confidence |